In this section you can find presentations from the previous Colorectal Cancer Screening Committee meetings.
2022 | 2021 | 2020 | 2019 | 2018 | 2017
Virtual CRC SC Meeting at APDW 2022 in Xi’an, China
CRC SC Meeting on November 17, 2022 | Program
| Third Asia Pacific Consensus Recommendations on Colorectal Cancer Screening | View Recording Here |
Hybrid Plenary Meeting in Vienna, Austria
Plenary Meeting on October 7, 2022 | Program
Session 1: CRC Screening policy update
| Global CRC incidence and mortality trends Linda Rabeneck (Canada) | |
| EU Recommendations on cancer screening Michael Kaminski (Poland) |
Session 2: Risk stratification in CRC screening
| Colonoscopy Prioritization Revital Kariv (Israel) |
Session 3: Participation in CRC screening
| The role of Defensive Information Processing in population-based colorectal cancer screening uptake Nick Clarke (Ireland) | |
| Reducing the footprint of CRC screening Iris Seriese (Netherlands) |
Session 4: Screen detected CRC
| CRC: indication for ESD Yutaka Saito (Japan) | |
| Screen detected T1 CRC in the Netherlands Lisa van der Shee (Netherlands) |
Expert Working Group Meeting in Vienna, Austria
EWG Meeting on October 7, 2022
FIT for Screening
| Association of Fecal Immunological Test with the risk of gastroesophageal cancer within a population with an intermediate risk for cancer Zohar Levi (Israel) | |
| A survey aimed to collect quantitative information about screening activity during the pandemic emergency Carlo Senore (Italy) |
PCCRC & Quality in Colonoscopy
| Molecular pathways in post-colonoscopy versus prevalent colorectal cancers: results from a population-based cohort study Beatriz Carvalho (Netherlands) |
Inequities in CRC Screening
| Colorectal Cancer Screening during Pandemic Samar Alhomoud (Saudi Arabia) | |
| Participation during the Covid pandemic Morten Rasmussen (Denmark) | |
| Factors associated with participation in the Dutch CRC screening program Esther Toes-Zoutendijk (Netherlands) |
Surveillance after Colorectal Neoplasia
| Post-surgery endoscopy surveillance for colorectal cancer Giulio Antonelli (Italy) | |
| Surveillance after endoscopic excision of pT1 malignant polyp. Is that different? Maria Pellisé & Rodrigo Jover (Spain) |
Polyp detection, characterization, resection and AI
| CADe, CADx – how good is it and how good should it be? Roupen Djinbachian (Canada) | |
| Beyond AI diagnosis: New evidence of ESD, suggesting a refined management of colorectal neoplasm Yutaka Saito (Japan) |
Hybrid Plenary Meeting in San Diego, USA
Plenary Meeting on May 20, 2022 | Program
Session 1: Early-onset
| Prevalence of colorectal neoplasia in young individuals / GIQuIC: Yield of screening 45–49-year-olds Parth Trivedi (USA) | |
| Fight CRC: Integrating Stakeholders with Research Initiatives in Early-onset Colorectal Cancer Jennifer Kolb, Caitlin Murphy (USA) | |
| Potential Effects of Lowering Colorectal Cancer Screening Age to 45 Years on Colonoscopy Demand, Case Mix, and Adenoma Detection Rate Seth Crockett (USA) |
Session 2: New tests
| Review on regional variation in microbiome Mingyang Song (USA) | |
| Update for the WEO Expert Working Group on New Test Evaluation: Assessing the cost effectiveness of new tests Uri Ladabaum (USA) |
Session 3: Risk-based screening and encouraging uptake
| Risk-based screening versus FIT for detecting advanced neoplasia: A within group comparison in a randomized controlled trial Tim Kortlever (Netherlands) | |
| Using Facebook to promote the uptake of colorectal cancer screening Arlinda Ruco (Canada) | |
| M-TICS: A study to assess the effectiveness of SMS-based interventions to increase participation in a population-based colorectal cancer screening program Montse Garcia (Spain) |
Session 4: Emerging trends
| Green endoscopy Heiko Pohl (USA) | |
| How to measure equity by race and ethnicity and socio-economic status, and what to do about the results. An update along with results from recent letter in NEJM Chyke Doubeni (USA) | |
| Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study David van Toledo (Netherlands) | |
| Comparing Colorectal Cancer Screening Outcomes in the International Cancer Screening Network (ICSN): A Consortium Proposal Iris Lansdorp-Vogelaar (Netherlands) |
Hybrid Expert Working Group Sessions in San Diego, USA
EWG sessions on May 20, 2022 | Program
Session 1: EWGs Surveillance after Colorectal Neoplasia and Polyp detection, characterization, resection and AI
| Why people at high risk remain at high risk after polyp excision Samir Gupta (USA) | |
| EPoS study update Rodrigo Jover (Spain) |
| Incomplete resection, complete resection and polyp recurrence Roupen Djinbachian (Canada) | |
| Benefits and limitations of using CADx in colonoscopy: learning from the first comparative clinical trial Sophie Williams (UK) |
Session 2: EWGs FIT for Screening and Evaluation of new tests
| A trial of 50,000 US Veterans who were randomized to colonoscopy vs. FIT Jason Dominitz (USA) | |
| Adherence to FIT Screening Paul Limburg (USA) | |
| Cost effectiveness of outreach strategy for stool-based CRC screening Durado Brooks (USA) | |
| Two-sample Fecal Immunochemical Testing as a Tool to avert Colonoscopy in Symptomatic Patients Pieter Wisse (Netherlands) |
| Progress with consensus process | Uri Ladabaum’s presentation from plenary meeting Robert Bresalier (USA) |
Session 3: Case Studies: Impact of COVID-19
| Impact of COVID Pandemic on FIT-Based CRC Screening Programs in 3 Countries: What Does Modeling Tell Us? Iris Lansdorp-Vogelaar (Netherlands) | |
| Impact of COVID Pandemic on CRC Screening Ontario: What Did We Learn? Jill Tinmouth (Canada) | |
| Impact of COVID Pandemic on FIT Use, Colonoscopy, and Neoplasia Detection: Lessons from Kaiser Permanente Theodore Levin (USA) |
Expert Working Groups: Inequities in CRC Screening & Screening in a COVID-19 Era
Webinar on December 9, 2021 | Program
| The impact of delays in screening invitations on outcomes of screening: an analysis based on individual-level data Esther Toes-Zoutendijk (Netherlands) | |
| The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities Jesse Nodora (USA) | |
| Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study Meghan Walker (Canada) |
Expert Working Groups: PCCRC & Quality in Colonoscopy and Surveillance after Colorectal Neoplasia
Webinar on December 2, 2021 | Program
| National PCCRC audit project in England – progress, logistics, lessons learned, how to implement elsewhere Roland Valori (UK) | |
| Colonoscopy provider reporting in Ontario, Canada Jill Tinmouth (Canada) | |
| Post-Colonoscopy Cancer: Giving Feedback to the Endoscopist Silvia Sanduleanu (Netherlands) | |
| The evidence on the effectiveness of surveillance: What is known, evidence gaps, future research Amanda Cross (UK) | |
| Should colonoscopy quality be integrated into surveillance recommendations? Paulina Wieszczy (Poland) | |
| Update on FORTE, including how to handle research as guidelines change Robert Schoen (USA) |
Expert Working Group: Polyp detection, characterization, resection and AI
Webinar on November 25, 2021 | Program
| Embedding optical biopsy recommendation in the NICE statements in the UK and possibility to include AI in the NICE James East (UK) | |
| Standard polypectomy – how can we improve complete polyp resection? Daniel von Renteln (Canada) | |
| Polypectomy – Teaching and Training Kevin Waschke (Canada) | |
| Endoscopic resection for large colorectal polyps Jeffrey Mosko (Canada) |
Expert Working Groups: Evaluation of New Tests & FIT for Screening
Webinar on November 16, 2021 | Program
| Report on consensus process of the guiding principles Graeme Young (Australia) | |
| What is a reasonable comparator test to run against for new tests Carlo Senore (Italy) | |
| Validation of a new test in CRC screening –How we did it. Veerle Coupé, Beatriz Carvalho (Netherlands) | |
| Gut microbiome biomarker for colorectal cancer and adenoma Jun Yu (Hong Kong) |
Virtual Plenary Meeting
on October 1, 2021 | Program
Session 1: Expert Working Group Session
| WEO recommendation statement for dealing with future healthcare crises: a Delphi panel Iris Lansdorp-Vogelaar (Netherlands) | |
| Bowel Cancer Screening Uptake & CRC Diagnosis All Pathways – a four-year audit 2017-2020 Andrew Prentice (UK) | |
| Updating the New Test Evaluation Guidelines Carlo Senore (Italy) | |
| Global burden of post-colonoscopy colorectal cancer – current status and future directions Jeffrey Lee (USA) | |
| Current status and future perspectives of polyp detection and characterization Daniel von Renteln (Canada) | |
| Optimizing surveillance: Less overall – but what to do in high-risk patients? Rodrigo Jover (Spain) | |
| Diagnostic yield using a FIT-based risk model was not better than FIT only: a randomized controlled trial in the second round of the Dutch colorectal cancer screening program Tim Kortlever (Netherlands) |
Session 2: Early-onset CRC
| Prevalence of neoplasia and ADR targets in 45-49-year olds Aasma Shaukat (USA) | |
| Impact of family history of CRC on the prevention of early-onset CRC: a multicenter study Maria Daca Alvarez (Spain) |
Session 3: Non-invasive CRC Screening
| Novel microbial-based stool markers for CRC and adenoma detection Francis Chan (Hong Kong) |
Session 4: AI in CRC Screening
| AI for polyp detection – what is unknown? Yuichi Mori (Norway) | |
| Blood-based CRC screening using multiomics and artificial intelligence/machine learning Theodore R. Levin (USA) |
Virtual Plenary Meeting
on May 20, 2021 | Program
Session 1: COVID-19 / Risk stratification
| Effect of COVID-19 on Colorectal Cancer Screening Karen Canfell (Australia) | |
| Risk stratified intervals for FIT screening Iris Lansdorp-Vogelaar (Netherlands) | |
| Risk stratification for screening in the wake of COVID-19 Marco Zappa (Italy) | |
| Incorporating demographic algorithms to improve FIT screening Patrick Bossuyt (Netherlands) |
Session 2: Quality
| Transforming colorectal cancer research findings into policy action Gloria Coronado (USA) | |
| Improving screening quality in Ontario, Canada Catherine Dubé (Canada) |
Session 3: Colonoscopy
| Systematic review on tailoring surveillance of high-risk lesions Sandra Baile-Maxia (Spain) | |
| PCCRC – auditing report from the UK Roland Valori (UK) | |
| Is colonoscopy less effective in the right colon? Ulrike Haug (Germany) | |
| Analysis and categorization of PCCRCs using the WEO guidelines Matt Rutter (UK) |
Session 4: Multi-cancer screening with ctDNA/methylation markers
| Review and reports from the latest studies Robert Schoen (USA) | |
| Design of trials going forward Carlo Senore (Italy) |
Expert Working Group: Screening in the COVID-19 Era
Webinar on May 11, 2021 | Program
| COVID and Cancer Global Modeling Consortium: Projections of the long-term impact of disruptions to colorectal cancer (CRC) screening programs Eleonora Feletto (Australia) | |
| COVID-19 and the Dutch national CRC screening program: Short term outcomes and optimal strategies to mitigate long term impact Tim Kortlever, Lucie de Jonge (Netherlands) | |
| ICSN CRC working group initiative to monitor the impact of COVID-19 on CRC screening programs across the world Carlo Senore (Italy) |
Expert Working Group: Inequities in CRC Screening
Webinar on May 6, 2021 | Program
| Advocating for a Medicaid Colorectal Cancer Screening Performance Metric – Lessons Learned and Progress to Date Beverly Green (USA) | |
| Barriers to colonoscopy in the English Bowel Screening Programme: findings from a key informant interview study Robert Kerrison (UK) | |
| Small-area Analysis of Participation Rates in a Colorectal Cancer Screening Program in Catalonia Montse Garcia (Spain) | |
| Barriers to Bowel Screening in Welsh Prisons: A Literature Review Mary Keast (UK) |
Expert Working Group: FIT for Screening
Webinar on April 29, 2021 | Program
| CRC screening in COVID times Sally Benton (UK) | |
| Impact of program design on rates of rejected fecal tests in Ontario, Canada Catherine Dubé (Canada) | |
| The impact of COVID-19 on the FIT-based program in the Netherlands Tim Kortlever (Netherlands) | |
| Using prior Hb concentration for risk-stratified intervals of FIT screening – rationale for and design of a randomized controlled trial in the Netherlands Iris Lansdorp-Vogelaar (Netherlands) | |
| Variation in f-Hb concentration means that 2 samples are better than one Graeme Young (Australia) |
Expert Working Groups: Right-Sided Lesions/Interval Cancers and Surveillance after Colorectal Neoplasia
Webinar on April 22, 2021 | Program
| Is there a role of an interval FIT for the prevention of PCCRC? Han-Mo Chiu (Taiwan) | |
| Are PCCRCs more lethal compared to detected CRCs? | The view from Sweden Anna Forsberg (Sweden) | |
| Are PCCRCs more lethal compared to detected CRCs? | The view from Canada Fahima Dossa (Canada) | |
| Are we successfully reducing CRC risk in patients with baseline High Risk Adenomas? Uri Ladabaum (USA) |
Expert Working Group: Evaluation of New Tests
Webinar on April 13, 2021 | Program
| What is the screening target? Uri Ladabaum (USA) | |
| How good need the new test be? Graeme Young (Australia) | |
| Discussion on: What is the screening target? Beatriz Carvalho (Netherlands) | |
| Algorithms in CRC screening Tim Kortlever (Netherlands) | |
| Design issues Carlo Senore (Italy) | |
| Statistical approaches Patrick Bossuyt (Netherlands) | |
| How do we get new CRC screening tests from bench to bedside? Robert Bresalier (USA) |
Expert Working Group: Polyp detection, characterization, resection and AI
Webinar on April 8, 2021 | Program
| How do we handle the detection of an increasing number of tiny adenomas? Masau Sekiguchi (Japan) | |
| Is the idea of R&D still relevant? Daniel von Renteln (Canada) |
Expert Working Group: Coalition to Reduce Inequities in CRC Screening
Webinar on November 20, 2020 | Program
| Disgusted, embarrassed, afraid: Affective predictors of colonoscopy avoidance Lynne Klasko-Foster (USA) | |
| Covid-19 and follow up of patients with abnormal FIT Andrew Prentice (UK) | |
| The impact of hypothetical PErsonalised Risk Information on informed choice and intention to undergo Colorectal Cancer screening colonoscopy in Scotland (PERICCS) Jayne Digby (UK) | |
| Interventions to improve the follow-up of positive FIT: An international survey of screening programs Kevin Selby (Switzerland) |
Colorectal Cancer Screening Committee Virtual Meeting (Europe)
UEG Week | October 9, 2020 | CRC SC Abstracts | Program
Session 1: Colorectal Cancer Screening in a COVID-19 era
| COVID-19: The forefront of virus management Ernst Kuipers (Netherlands) | |
| Global news on CRC Screening in the COVID-19 era Stephen Halloran (UK) | |
| Optimizing Endoscopy Efficiency and flow during and after COVID-19 Aasma Shaukat (USA) | |
| COVID-19: Endoscopy services, PPE, pre-procedure testing Asadur Tchekmedyian (Uruguay) | |
| Experience and Impact of Delays in Endoscopy on Bowel Cancer Screening Siwan Thomas-Gibson (UK) | |
| Changes in the numbers of US patients with newly identified cancer before and during COVID-19 Randy Howard (USA) |
Session 2: Outreach & increasing participation in population-based programs
| Implementing Ontario’s CRC screening program: The first 10 years Linda Rabeneck (Canada) | |
| Organized CRC screening outreach Eeforts in various countries and health systems Jason Dominitz (USA) | |
| Model-based comparison of measures for longitudinal screening adherence Veerle Coupé (Netherlands) |
Session 3: Looking hard for polyps
| Artificial Intelligence for polyp detection Raf Bisschops (Belgium) | |
| Optimizing polyp resection Heiko Pohl (USA) | |
| Clinical features, outcomes and risk factors for bleeding after endoscopic resection of submucosal invasive colorectal Ji-Taek Hong (Korea) | |
| Polyp Surveillance Guidelines from the US and EU Samir Gupta (USA) |
Session 4: Programmatic issues
| Update on Early-Onset Colorectal Cancer (EOCRC) Thomas Imperiale (USA) | |
| Launching the European Commission Initiative on Colorectal Cancer (ECICC) Elena Parmelli (Italy) | |
| Post-Colonoscopy CRC over the Globe Matthew Rutter (UK) |
Colorectal Cancer Screening Committee Meeting Barcelona (Europe) UEG Week 2019 | October 18, 2019 | CRC SC Abstracts | Program
Session 1: Colonoscopy: good, better, best?
| Training for optical recognition of early cancer Krijn Haasnoot (Netherlands) |
| Update on the CONFIRM study Jason Dominitz (USA) |
Session 2: New light on CRC epidemiology
| Early onset colorectal cancer Marc Bardou (France) |
| Effect of CRC screening on incidence Gavin Clark (UK) |
| Comparison of screen-detected and interval cancers in FIT screening Isabel Portillo Villares (Spain) |
| Mortality due to screen-detected and interval cancer Montse Garcia (Spain) |
Session 3: The international perspective: what is happening…where?
| Cancer screening in five continents: the IARC initiative Eric Lucas (France) |
| Update on CRC screening in Germany Urlike Haug (Germany) |
| Impact of CRC screening on incidence and mortality in the Czech Republic Stepan Suchanek (Czech Republic) |
Session 4: Issues to consider…
| Increase in faecal occult bleeding with time Robert Steele (UK) |
EWG: WEO Coalition to Reduce Inequities in CRC Screening
Agenda
| My best 10 seconds campaign Jolanta Gore Booth (Belgium) |
| Improving uptake of bowel cancer screening in the South Asian community Lesley Smith (UK) |
| Ethnic differences in bowel cancer screening awareness: findings from a pharmacy-based community survey Andrew Prentice (UK) & Sarah Marshall (UK) |
| Exploring non-attendance at colonoscopy among socioeconomically deprived and ethnically diverse populations taking part in FIT-based CRC screening Robert Kerrison (UK) |
EWG: FIT for Screening
Agenda
EWG: Image Enhanced Endoscopy and Endoscopic Therapy
Agenda
| What we need from AI in clinical practice Tom Eelbode (Belgium) |
EWG: Right-Sided Lesions and Interval Cancers
Agenda
| Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death Chyke Doubeni (USA) |
| How can application of the WEO consensus on PCCRC aetiology help reduce rates Nick Burr (UK) |
| PCCRC rate in the Dutch CRC program, work in progress Manon Spaander (The Netherlands) |
| IARC´s stock take of CRC Screening in Europe Carlo Senore (Italy) |
| CRC screening in middle income countries Rolando Camacho (WHO Europe Consultant) |
| Approaches to Colonoscopy Quality in Screening Roland Valori (UK) |
| Case Study: Portugal – Current Challenges Vitor Rodrigues (Portugal) |
| Case Study: Finland – New plans for FIT with a Difference (different thresholds for men and women) Tytti Sarkeala (Finland) |
| Case Study: Romania – Developing screening with help from EU and Successful Programs in Italy Mircea Manuc (Romania) |
| Case Study: Slovenia – An Early and Successful Organized Population based Screening Program Dominika Novak-Mlakar (Slovenia) |
| Case Study: Sweden: Implementation process Charlotta Sävblom (Sweden) |
Colorectal Cancer Screening Committee Meeting San Diego (Americas)
DDW 2019 | May 17, 2019 |Program
Session 1: Tribute to Professor Wendy Atkin
| Remembering Professor Wendy Atkin David Ransohoff (USA) |
| Using FIT for post-polypectomy surveillance Manon Spaander (the Netherlands) |
| Debate: A once only colonoscopy? Surveillance does not add much. True – Jeffrey Lee (USA) False – Samir Gupta (USA) |
| Debate: Adenoma Detection Rate: Have we gone too far? We have – Sameer Saini (USA) We have not – Peter S. Liang (USA) |
Session 2: Recent Advances in Science and Technology
| Young onset CRC and genetic risk factors Douglas Corley (USA) |
| CRC and microbiome signature Mingyang Song (USA) |
Session 4: Family history and Population Screening
| Family history and CRC screening: the Canadian consensus Jill Tinmouth (Canada) |
| Familial risk in those with a first degree relative with an advanced adenoma Jennifer Kolb (USA) |
| Cost-effectiveness and national impact of initiating average-risk CRC screening at age 45 instead of 50 Uri Ladabaum (USA) |
EWG: Right-Sided Lesions and Interval Cancers
Agenda
| PCCRC in Lynch Francesc Balaguer (Spain) |
EWG: Image Enhanced Endoscopy and Endoscopic Therapy
Agenda
| AI – Prediction of deep cancer invasion Leon Moons (Netherlands) |
| Priorities, challenges and barriers in implementing Artificial perception/intelligence in CRC screening and surveillance? Michael Byrne (Canada) |
Colorectal Cancer Screening Committee Meeting Prague (Europe)
ESGE Days 2019 | April 4, 2019 | Program
Session 1: Introductory session
| Principles of Organized Screening Linda Rabeneck (Canada) |
| Results of RCTs of CRC screening Jaroslaw Regula (Poland) |
| Ongoing RCTs of CRC screening – expected information Rodrigo Jover (Spain) |
| Original Research: Adenoma Detection Rate And Colonoscopy Indication: Beyond Screening Procedures Carolina Mangas-Sanjuan (Spain) |
Session 2: Colonoscopy in FIT(+) persons
| Adjusting existing colonoscopy quality indicators for FIT(+) persons Rodrigo Jover (Spain) |
| Need for new colonoscopy quality indicators for FIT(+) persons? Cesare Hassan (Italy) |
| Organizational issues for Endoscopy units providing colonoscopy in FIT(+) persons Evelien Dekker (The Netherlands) |
| Normal colonoscopy in FIT(+) persons: Dilemmas Krish Ragunath (UK) |
| Original research: Interval CRCs after negative FIT in a 13-year Screening Program Cesare Hassan (Italy) |
Colorectal Cancer Screening Committee Meeting Vienna (Europe)
UEG Week 2018 | October 19, 2018 | Program
Session 1: Endoscopy / Latest developments
| Artificial intelligence Rodrigo Jover (Spain) |
| Prediction of lymph node metastasis (LNM) in T1 CRCs Leon Moons (Netherlands) |
| Is there justification for levels of polyp competency? Roland Valori (UK) |
Session 2: Updates from screening programs
| Status of the screening program in the Canton of Vaud, Switzerland Kevin Selby (Switzerland) |
| Need for colorectal cancer screening in Saudi Arabia Samar Alhomoud (Saudi Arabia) |
| Initial findings from the Scottish Bowel Screening Program after changing to FIT Judith Strachan (UK) |
| Colorectal cancer screening in the regions of the Russian Federation Stanislav Konovalov (Russia) |
| Comparative analysis of the performance of EU screening programs Carlo Senore (Italy) |
Session 3: Should we start screening earlier?
| Screening start age in light of new ACS guidelines Charles Kahi (USA) |
Session 4: Trends and risk stratification
| Intelligent use of FIT Stephen Halloran (UK) |
EWG: WEO Coalition to Reduce Inequities in CRC Screening
Agenda
| Development and pilot-testing of a Colorectal Cancer Screening Decision Aid for individuals with low health literacy Mirjam Fransen (Netherlands) |
| Interventions to increase uptake in central London Robert Kerrison (England) |
EWG: FIT for Screening
Agenda
| Detectability characteristics Callum Fraser (UK) |
| Dynamic changes of faecal haemoglobin to assess the risk of advanced colorectal lesions Josep Auge (Spain) |
| Update on the colorectal cancer screening in East Europe and Central Asia Marcis Leja and Anna Krigere (Latvia) |
| Status of organised screening programs with FIT around the world Graeme Young (Australia) |
EWG: Right-Sided Lesions and Interval Cancers
Agenda
| PCCRC in high-risk cohorts – IBD Nick Burr (UK) |
| PCCRC in high-risk cohorts – Lynch syndrome Francesc Balaguer (Spain) |
| Right-sided cancer – is it down to a field effect? James East (UK) |
Colorectal Cancer Screening Committee Meeting Mar del Plata (South America)
GASTRO 2018 | September 28, 2018 | Program
| Rising Burden of Colorectal Cancer in Latin America Linda Rabeneck (Canada) |
| Novedades en preparación para colonoscopia Eduardo Coghlan (Argentina) |
| How to start a Screening Program: Uruguay Experience Eduardo Fenocchi (Uruguay) |
| Quality of Screening Colonoscopy – how to improve ADR Roque Saenz (Chile) |
| Interval Cancers Asadur Jorge Tchekmedyian (Uruguay) |
| Screening Program in Argentina: Lessons learned Julia Ismael (Argentina) |
Colorectal Cancer Screening Committee Meeting Washington (Americas)
DDW 2018 | June 1, 2018 | Program
Session 1: FIT
| Comparison of different FIT kits in the Dutch CRC screening program Clasine de Klerk (Netherlands) |
| Reasons for non-follow up after a positive FIT in the Dutch CRC screening program Lucinda Bertels (Netherlands) |
Session 2: Colonoscopy Quality
| Management of pT1 polyps Maria Pellisé (Spain) |
| Colonoscopy Upskilling Donald MacIntosh (Canada) |
Session 3: Screening and Surveillance
| CTC vs. Colonoscopy for surveillance after CRC David Weinberg (USA) |
| Number of adenomas Needed to Remove (NNR) and Dwell time avoided – metrics for assessing screening Efficiency Paul Pinsky (USA) |
| Evaluation and comparison of the effectiveness of CRC screening tests: The IARC Handbook Béatrice Lauby-Secretan (France) |
| CRC screening at age 45 – What does the modeling suggest? Elisabeth Peterse (Netherlands) |
Session 4: New Technology and New Understandings/Realizations
| Rates and complications of surgery for non-malignant polyps Anne Peery (USA) |
| Genetics in young onset CRC Elena Stoffel (USA) |
| Deep learning for prediction of advanced neoplasia Hyo-Joon Yang (Korea) |
| Deep learning for real time histologic differentiation Michael Byrne (Canada) |
The WEO CRC Screening Committee 20th Anniversary
A Historical Recounting – Graeme Young (Australia)
EWG: Right-Sided Lesions and Interval Cancers
Agenda
| Serrated polyp detection rates and factors associated with detection Seth Crockett (USA) |
| PCCRC: where next? Douglas Corley, USA |
EWG: Colonoscopy Screening Trials
Agenda
| National Colonoscopy Study (NCS) Ann Zauber, USA |
| Predictive Modeling based on NCS Reinier Meester, USA |
| CONFIRM Trial Douglas Robertson, USA |
| COLONPREV Trial Enrique Quintero, Spain |
| NordiCC Trial Magnus Loberg, Norway |
EWG: WEO Coalition to Reduce Inequities in CRC Screening
Agenda
EWG: FIT for Screening
Agenda
| A Swedish update from SCREESCO Rolf Hultcrantz, Sweden |
| Effectiveness of WhatsApp reminder on compliance of colorectal cancer screening Thomas Lam, Hong Kong |
| Detection in subsequent screen round in the Netherlands: results for two cut-off levels Arthur Kooyker, The Netherlands |
| The Brazilian Pilot, an update Adriana Safatle-Ribeiro, Brazil |
EWG: Surveillance after Colorectal Neoplasia
Agenda
| General assumptions for surveillance guidelines: endpoints, cutoffs and comparators Rodrigo Jover (Spain) |
| Performance targets for lesion detection in Surveillance Uri Ladabaum (USA) |
| More vs. less intensive surveillance after polypectomy: Results from microsimulation modeling Reinier Meester (USA) |
EWG: Image Enhanced Endoscopy (IEE)
Agenda
| Computer aided optical diagnosis of polyps Michael Byrne (Canada) |
Colorectal Cancer Screening Committee Meeting Brasil (South America)
SBAD 2017 | November 11, 2017 |Program
Session 1
| Colorectal cancer: Why prevent it? Linda Rabeneck (Canada) |
| Screening for colorectal cancer: Global vision Linda Rabeneck (Canada) |
| How to start a screening program? Roque Saenz (Chile) |
Pilot studies in the prevention of colorectal cancer in Brazil
| Projeto Belterra Marcelo Averbach (Brazil) |
| Prevenção do CCR no Hospital Universitário de São Paulo Luis Masuo Maruta (Brazil) |
Session 2
| What’s the best test for population screening and surveillance Heiko Pohl (USA) |
| What’s the best test for population screening and surveillance Heiko Pohl (USA) |
| Quality of screening colonoscopy Heiko Pohl (USA) |
| Interval cancers Heiko Pohl (USA) |
Colorectal Cancer Screening Committee Meeting Barcelona (Europe)
UEG Week 2017 | October 27, 2017 | Program
Session 2: Novel Use of Tests
| Colon capsule in FIT+ Gunnar Baatrup (Denmark) |
| CRC risk stratification module M Azzam Kayasseh (UAE) |
| Novel optical sensor in toilet Shlomo Lewkowicz (Israel) |
Session 3: FIT
| Risk scoring in symptomatic patients incorporating FIT Jayne Digby (Scotland) |
| FIT: A Tale of Two Settings Callum G Fraser (Scotland) |
| Comparison of FIT performance in screening programs Carlo Senore (Italy) |
Session 4: Quality
| Quality measures for individuals, institutions and programs Roland Valori (UK) |
| ESGE Quality indicators: implementation in ongoing programs Cesare Hassan (Italy) |
| Diminutive polyps and high risk status Jasper Vleugels (Netherlands) |
Session 5: Screening Program Updates
| Results from the Danish colorectal screening program Morten Rasmussen (Denmark) |
| Impact of gFOBT screening in England on CRC incidence and mortality Richard F A Logan (UK) |
EWG: Surveillance after Colorectal Neoplasia
Agenda
| Aim of the Project Rodrigo Jover (Spain) |
| Methodological Approaches Cesare Hassan (Italy) |
| Endpoints for Surveillance Studies Michael Bretthauer (Norway) |
| Potential PICOs Carlo Senore (Italy) |
| WEO Update of Evidences about Surveillance |
EWG: Right-Sided Lesions and Interval Cancers
Agenda
| WEO Consensus on PCCRC Iosif Beintaris (UK) |
| Natural history of right-sided lesions Jasper Vleugels (The Netherlands) |
| Optimal KPI for right-sided lesions James East (UK) |
| Should right-sided lesions be surveilled differently than left-sided? Paulina Wieszczy (Poland) |
| Expert Working Group Report |
EWG: FIT for Screening
Agenda
| Summary Ernst Kuipers (The Netherlands), Sally Benton (UK) |
| The Dutch colorectal cancer screening programme: first and second round Esther Toes (The Netherlands) |
| Increased Screening Cut-off Levels and Impact of a Plasma Protein Algorithm Hans Jørgen Nielsen (Denmark) |
| Comparison of surveillance in low risk adenomas: Colonoscopy vs. FIT Isabel Portillo (Spain) |
| The Risk of Missing Upper Gastrointestinal Cancer in Fitpositives in a Colorectal Cancer Screening Program Manon van der Vlugt (The Netherlands) |
| FIT ‐ Analytical Standardisation and Harmonisation Sally C Benton (UK) |
EWG: Coalition to Reduce Inequities in CRC Screening
Agenda
| Socioeconomic differences Andrea Burón (Spain) |
Colorectal Cancer Screening Committee Meeting Hong Kong (Asia-Pacific)
APDW 2017 | September 25, 2017 | Program
Session 1: New Technology I
| Real-world Big Data analysis and CRC Screening Hyun-Soo Kim (Korea) |
| Microbiome as a marker for CRC screening Sunny Wong (Hong Kong) |
Session 2: New Technology II
| Endocuff, EndoRings, FUSE and other devices Rupert Leong (Australia) |
| A blood based biomarker for screening for colorectal cancer KG Yeoh (Singapore) |
Session 3: Original Research
| Results of screening and surveillance colonoscopy in young Korean adults < 50 years Jae Myung Cha (Korea) |
| Full Spectrum Endoscopy (FUSE) in the detection of inflammatory bowel disease neoplasia (FUSION) Rupert Leong (Australia) |
| Molecular imaging of colonic adenomas with fluorescent tilmanocept Jeanette Méndez (USA) |
| VIST – new imaging techniques for in vivo characterization of colorectal polyps Ge Nan (China) |
| Establishment of an algorithm to reduce the numbers of FIT screening directed colonoscopies Hans Jørgen Nielsen (Denmark) |
Session 4: New Practices
| Young onset CRC worldwide: is this a new trend? Moe Kyaw (Hong Kong) |
| Colonoscopy surveillance: International cohort studies Ernst Kuipers (The Netherlands) |
Colorectal Cancer Screening Committee Meeting Chicago (Americas)
DDW 2017 | May 5, 2017 | Program
Session 2: Long-term risk of colorectal cancer
| Adenomas and long-term CRC risk in the PLCO trial Benjamin Click (USA) |
| Long-term CRC risk in the UK FlexiSig trial Wendy Atkin (UK) |
Session 3: FIT testing
| Issues and unknowns when comparing FIT tests Esmée Grobbee (Netherlands) |
| USPSTF Guidlines for CRC screening: How we arrived at what we recommended Sue Curry (USA) |
Session 4: Risk groups/Evaluating Risk
| Risk assessment tools Graham Radford-Smith (Australia) |
| Stool DNA testing: A Closer Look at Specificity David Ahlquist (USA) |
EWG: Colonoscopy Screening Trials
Agenda
| Global Burden of Disease Roque Saenz (Chile) |
EWG: Right-Sided Lesions and Interval Cancers
Agenda
EWG: FIT for Screening
Agenda
| Predictors of Timely Colonoscopy After a Positive Fecal Immunochemical Test (FIT) in the CONFIRM Study Douglas Robertson (USA) |
| Success of Mailed FIT in the United States Samir Gupta (USA) |
| Dutch roll out of FIT has led to an increase in cancer detection Manon Spaander (The Netherlands) |
| Sample Stability 16S and metagenomics analysis in OC-Sensor sample bottles Marcis Leja (Latvia) |
| FIT Resource Impact: The Calgary Experience Robert Hilsden (Canada) |
EWG: Surveillance after Colorectal Neoplasia
Agenda
| Surveillance after neoplasia removal Rodrigo Jover (Spain) & Uri Ladabaum (USA) |
| Differences between guidelines for post-polypectomy surveillance: is that justified? David Lieberman (USA) |
| Effect of adenoma surveillance on colorectal cancer incidence: a multicentre cohort study Wendy Atkin (UK) |
| FORTE: Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomas Robert Schoen (USA) |
EWG: Image Enhanced Endoscopy (IEE)
Agenda
| Summary Report Heiko Pohl (USA) & David Hewett (Australia) |
EWG: WEO Coalition to Reduce Inequities in CRC Screening
Agenda